| Product NDC: | 49873-109 |
| Proprietary Name: | Stonarhini |
| Non Proprietary Name: | Chlorpheniramine maleate, phenylephrine |
| Active Ingredient(s): | 2; 5 mg/1; mg/1 & nbsp; Chlorpheniramine maleate, phenylephrine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 49873-109 |
| Labeler Name: | Sato Pharmaceutical Co., Ltd. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20011116 |
| Package NDC: | 49873-109-01 |
| Package Description: | 4 BLISTER PACK in 1 CARTON (49873-109-01) > 6 TABLET in 1 BLISTER PACK |
| NDC Code | 49873-109-01 |
| Proprietary Name | Stonarhini |
| Package Description | 4 BLISTER PACK in 1 CARTON (49873-109-01) > 6 TABLET in 1 BLISTER PACK |
| Product NDC | 49873-109 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Chlorpheniramine maleate, phenylephrine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20011116 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Sato Pharmaceutical Co., Ltd. |
| Substance Name | CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE |
| Strength Number | 2; 5 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |